Research ArticleImmunotherapy

Anti-CD20/CD3 T cell–dependent bispecific antibody for the treatment of B cell malignancies

See allHide authors and affiliations

Science Translational Medicine  13 May 2015:
Vol. 7, Issue 287, pp. 287ra70
DOI: 10.1126/scitranslmed.aaa4802

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article